Covington Fends Off Contraceptive IP Challenge for Actavis

Covington Fends Off Contraceptive IP Challenge for Actavis

Julie Triedman

In a big win for Actavis plc, the Federal Circuit on Wednesday reaffirmed a lower court decision that Actavis' patent for the popular low-estrogen birth control pill Lo Loestrin is valid and enforceable.

      LOAD MORE